GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Price-to-Free-Cash-Flow

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Price-to-Free-Cash-Flow

: N/A (As of Today)
View and export this data going back to 2021. Start your Free Trial

As of today (2024-04-23), Regencell Bioscience Holdings's share price is $6.44. Regencell Bioscience Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Hence, Regencell Bioscience Holdings's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Regencell Bioscience Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

RGC's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 21.05
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Regencell Bioscience Holdings's Free Cash Flow per Share for the six months ended in Jun. 2023 was $0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -78.80% per year.

During the past 5 years, Regencell Bioscience Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was -78.80% per year. The lowest was -147.90% per year. And the median was -113.35% per year.


Regencell Bioscience Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for Regencell Bioscience Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
- - - - -

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regencell Bioscience Holdings Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Price-to-Free-Cash-Flow falls into.



Regencell Bioscience Holdings Price-to-Free-Cash-Flow Calculation

Regencell Bioscience Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=6.44/0
=N/A

Regencell Bioscience Holdings's Share Price of today is $6.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regencell Bioscience Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Regencell Bioscience Holdings  (NAS:RGC) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Regencell Bioscience Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus